UNRESECTABLE
Clinical trials for UNRESECTABLE explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE trials appear
Sign up with your email to follow new studies for UNRESECTABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New daily pill hopes to shrink Hard-to-Treat tumors
Disease control Recruiting nowThis study tests an experimental daily pill, REC-1245, in 170 adults with advanced solid tumors or lymphomas that have not responded to standard treatments. The goal is to find a safe dose and see if the drug can shrink tumors or slow their growth. Participants will take the pill…
Matched conditions: UNRESECTABLE
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New combo therapy aims to boost lung cancer treatment success
Disease control Recruiting nowThis study tests a new way to give radiation therapy (using PET scans to target smaller areas) along with standard chemo and an immunotherapy drug (durvalumab) for people with stage III lung cancer that cannot be removed by surgery. About 110 adults will be randomly assigned to e…
Matched conditions: UNRESECTABLE
Phase: PHASE2 • Sponsor: TheraOp • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Radioactive implant fights pancreatic cancer from the inside
Disease control Recruiting nowThis early study tests a new treatment for pancreatic cancer that cannot be removed by surgery. Ten participants will receive a single injection of a radioactive implant directly into their tumor, along with standard chemotherapy. The goal is to see if the combination is safe and…
Matched conditions: UNRESECTABLE
Phase: NA • Sponsor: BetaGlue Therapeutics SpA • Aim: Disease control
Last updated Apr 26, 2026 19:35 UTC